Keyphrases
Bisphosphonate Treatment
100%
National Register
100%
Renal Function
100%
CKD Stage
42%
Population-based
28%
DXA Scan
28%
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)
28%
Acute Renal Injury
28%
Treatment Options
14%
Kidney Transplantation
14%
Safety Outcomes
14%
Bisphosphonates
14%
Osteoporosis
14%
Alendronate
14%
National Database
14%
Biochemical Analysis
14%
Hypocalcemia
14%
Absolute Gain
14%
Bisphosphonate Use
14%
Prescribers
14%
Medication Possession Ratio
14%
Low Use
14%
Small-gain
14%
Renal Dialysis
14%
Renal Function Decline
14%
Glomerulonephritis
14%
User Groups
14%
User Populations
14%
Medicine and Dentistry
Cohort Analysis
100%
Kidney Function
100%
Bisphosphonate
100%
Dual-Energy X-Ray Absorptiometry
44%
Kidney Injury
22%
Drug Therapy
11%
Kidney Transplantation
11%
Randomized Controlled Trial
11%
Hemodialysis
11%
Osteoporosis
11%
Biochemical Analysis
11%
Glomerulonephritis
11%
Hypocalcaemia
11%
Creatinine Clearance
11%
Alendronic Acid
11%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Bisphosphonic Acid Derivative
100%
Kidney Injury
66%
Randomized Controlled Trial
33%
Hemodialysis
33%
Alendronic Acid
33%
Creatinine
33%
Hypocalcaemia
33%
Glomerulonephritis
33%
Biochemistry, Genetics and Molecular Biology
Cohort Study
100%
Kidney Function
100%
Randomized Controlled Trial
11%
Creatinine Clearance
11%
Biochemical Analysis
11%
Hypocalcaemia
11%